Read the full article here.
This content was originally published by McKinsey Insights & Publications. Original publishers retain all rights. It appears here for a limited time before automated archiving. By McKinsey Insights & Publications
To respond best to the changes driven by the COVID-19 pandemic, pharma companies should consider reorienting their commercial models to fit the needs of healthcare providers and patients better.